Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.50
Bid: 0.00
Ask: 280.00
Change: 0.00 (0.00%)
Spread: 20.00 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 261.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Apr 2015 08:15

RNS Number : 1252J
Synthomer PLC
01 April 2015
 

01 April 2015 

Synthomer plc

Appointment of Chief Financial Officer

Synthomer plc ('Synthomer' or 'the Company') announces that it has appointed Steve Bennett as its Chief Financial Officer. Steve will join Synthomer in July and will succeed David Blackwood, who announced in December that he would step down from the role after seven years. David will leave the Company after a brief handover period.

Steve joins from INEOS Group ('INEOS') where he has been Chief Financial Officer at Petroineos Refining Limited, a JV between INEOS Group AG and PetroChina, since 2006. In addition to this role, he has acted as Chief Financial Officer of INEOS Upstream Limited, a start-up oil and gas exploration business, and of INEOS Olefins and Polymers South and INEOS Phenol.

Steve joined Coopers & Lybrand in 1986 and is a qualified Chartered Accountant. He joined Full Circle Industries plc as Company Secretary and Group Controller before moving to PricewaterhouseCoopers ('PWC') in 1997 as a Director in Transaction Services. At PWC, he specialised in public and private equity transactions across a variety of sectors including chemicals.

Neil Johnson, Chairman, said:

"I am delighted to welcome Steve to Synthomer. He has a superb track record at INEOS and thirty years of experience working in finance across a broad range of sectors, not least the chemical industry. I have no doubt that Steve's considerable knowledge and skills will be invaluable to the Group as we move forward.

On behalf of the Board, I would once again like to thank David for his seven years of service. His contribution has been instrumental in helping Synthomer through a significant transformation and we wish him all the best for the future."

Calum MacLean, Chief Executive, said:

"I have known Steve for the past ten years and I am delighted to welcome someone of his calibre to Synthomer. His significant experience will be of enormous benefit to me and the senior team as we look to take Synthomer into a new phase of its growth."

There are no further details required to be disclosed under LR 9.6.13R of the Listing Rules of the UK Listing Authority.

-ENDS-

Enquiries:

Synthomer plcNeil Johnson, ChairmanCalum MacLean, Group Chief Executive

 

+ 44 (0) 1279 436 211

Pendomer Charles Armitstead

+44 (0) 20 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUAABRVSASRRR
Date   Source Headline
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.